Ongoing Research
A Phase III Open-Label Extension Study to Evaluate the Long-Term Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease
Principal Investigator — Dr. Charles Y. Yu
Status — Ongoing
A phase 2, partially-blinded, randomised Study assessing the safety and efficacy of TBAJ876 or bedaquiline, in combination with pretomanid and linezolid in adult participants with newly diagnosed, drug-sensitive, smear- positive pulmonary tuberculosis
Principal Investigator — Dr. Charles Y. Yu
Status — Ongoing
Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous selatogrel for prevention of all-cause death and treatment of acute myocardial infarction in subjects with a recent history of acute myocardial infarction
Principal Investigator — Dr. Andre Luis R. Agoncillo
Status — Ongoing
A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease
Principal Investigator — Dr. David Raymund K. Salvador
Status — Ongoing
Phase 3, Global, Randomized, Double-blind, Placebo-controlled, Safety and immunogenicity Study of CHIKV VLP Vaccine in Children 2 to <12 Years of Age
Principal Investigator — Dr. Delia C. Yu
Status — Ongoing